Shaddari
Shaddari Inc. is a precision medicine company that offers hospitals tools to rapidly assess the right dosage of a drug in an emergency situation and thus prevent the more than 2 millions medication accidents that happen every year in North America. Our goal is to help doctors safely treat their patients at the most individualized precision level using Artificial Intelligence.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | CAD350k | Grant |
| Total Funding | 000k | ||
Related Content
Shaddari Inc. operates in the healthcare technology sector, providing advanced artificial intelligence (AI) solutions to hospitals and healthcare providers. The company's core product, Sentinel 24, is a virtual queuing and clinical decision support system designed to enhance hospital productivity and patient safety. Sentinel 24 helps hospitals maintain patient flow while adhering to social distancing measures, a critical need in the post-COVID era. The system leverages AI to predict the effects of medications before administration, thereby preventing adverse medication events and optimizing patient care. Shaddari's technology also aids in rapid dosage calculations, eliminating the need for manual processes and complex tools. Additionally, Shaddari offers an AI-based decision support system for vaccine selection, which helps immunologists identify the best vaccine using target gene sequences, thereby improving positive outcomes. Shaddari generates revenue through contracts with healthcare institutions and by offering trials and subscriptions for its technology solutions.
Keywords: AI, clinical decision support, virtual queuing, patient safety, hospital productivity, adverse medication events, vaccine selection, healthcare technology, COVID-19 response, immunology.